FDA Robotics Discussion Paper: Autonomous and Remotely Teleoperated Devices

Authority type

Federal Agency Discussion Paper

Jurisdiction

United States

Issuing body

U.S. Food and Drug Administration

Citation

Discussion paper, Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities (Nov. 6, 2026), Docket FDA-2026-N-13135

Legal status

Discussion paper; feedback requested

Last reviewed

November 9, 2026

FDA released a discussion paper on autonomous and remotely teleoperated robotic medical devices on November 6, 2026. It addresses terminology, benefits, risks, and possible risk mitigations across surgical and nonsurgical applications. The paper is neither draft nor final guidance and does not establish new regulatory expectations. Feedback is requested by January 5, 2027, in Docket FDA-2026-N-13135.

Law checked through November 9, 2026.

Sources

• FDA discussion paper, Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities

Related guides

• Healthcare and Surgical Robotics

About Jason Blackstone